Efficacy of rituximab treatment in a post-COVID-19 vaccine myositis overlapping to systemic sclerosis: a histological follow-up.
Saved in:
| Title: | Efficacy of rituximab treatment in a post-COVID-19 vaccine myositis overlapping to systemic sclerosis: a histological follow-up. |
|---|---|
| Authors: | Bandinelli F; SOC of Rheumatology, Multi-Dimensional Department, Santa Maria Nuova and San Giovanni di Dio Hospitals, USL Tuscany Center, Florence, Italy. francesca.bandi@gmail.com., Dallagiacoma G; SOC of Rheumatology, Multi-Dimensional Department, Santa Maria Nuova and San Giovanni di Dio Hospitals, USL Tuscany Center, Florence, Italy., Nozzoli F; Department of Health Sciences, Section of Pathological Anatomy, University of Florence, Italy., Capassoni M; SOC of Rheumatology, Multi-Dimensional Department, USL Tuscany Center, Prato, Italy., Nassini R; Department of Health Sciences and Headache Center, Clinical Pharmacology Unit, Section of Clinical Pharmacology and Oncology, Careggi University Hospital, University of Florence, Italy. |
| Source: | Clinical and experimental rheumatology [Clin Exp Rheumatol] 2026 Feb; Vol. 44 (2), pp. 415-416. Date of Electronic Publication: 2026 Jan 30. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Clinical And Experimental Rheumatology S.A.S Country of Publication: Italy NLM ID: 8308521 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0392-856X (Print) Linking ISSN: 0392856X NLM ISO Abbreviation: Clin Exp Rheumatol Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| ISSN: | 0392-856X |
|---|---|
| DOI: | 10.55563/clinexprheumatol/8xtlep |
